Literature DB >> 11324779

Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.

J A Husted1, D D Gladman, V T Farewell, R J Cook.   

Abstract

OBJECTIVE: To compare health-related quality of life (QOL) between patients with psoriatic arthritis (PsA) and patients with rheumatoid arthritis (RA), using the Medical Outcomes Study Short Form health survey (SF-36) and the Health Assessment Questionnaire (HAQ).
METHODS: Both the SF-36 and the HAQ were administered to 107 PsA patients attending the University of Toronto Psoriatic Arthritis Clinic between January 1 and December 31, 1994, and to 43 RA patients attending a University of Toronto-affiliated RA clinic during the same period. Standardized assessments of disease activity and severity were also performed at each clinic visit. Logistic regression analysis was used to compare health-related QOL between PsA and RA.
RESULTS: Both patient populations experienced lower physical health compared with that of a general population sample. The RA patients demonstrated more active inflammatory disease at the time of assessment than the PsA patients. The PsA patients were younger, and more were men. Logistic regression analyses showed that patients with PsA reported higher levels of vitality than patients with RA, even after adjusting for the observed differences in clinical and demographic characteristics. PsA patients, however, reported more role limitations due to emotional problems and more bodily pain after adjusting for the difference in vitality and other covariates.
CONCLUSIONS: Although both patient populations experienced reduced QOL, there were some meaningful differences in how the 2 conditions affect health-related QOL. Further, it appeared that there may be unique disabilities associated with the psoriasis dimension of PsA.

Entities:  

Mesh:

Year:  2001        PMID: 11324779     DOI: 10.1002/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  102 in total

1.  TNFalpha therapy in psoriatic arthritis and psoriasis.

Authors:  P Mease
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

2.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

Review 3.  Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability.

Authors:  William J Taylor
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

4.  Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.

Authors:  A Kavanaugh; G G Krueger; A Beutler; C Guzzo; B Zhou; L T Dooley; P J Mease; D D Gladman; K de Vlam; P P Geusens; C Birbara; D G Halter; C Antoni
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

Review 5.  Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology.

Authors:  Philip Mease
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

6.  Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Authors:  Zrinka Jajić; Ivana Rajnpreht; Nataša Kovačić; Ivan Krešimir Lukić; Vedran Velagić; Frane Grubišić; Ana Marušić; Danka Grčević
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

Review 7.  Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?

Authors:  D D Gladman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

8.  A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis.

Authors:  Pinar Borman; Guneş Gur Toy; Seçil Babaoğlu; Hatice Bodur; Deniz Ciliz; Nuran Alli
Journal:  Clin Rheumatol       Date:  2006-04-19       Impact factor: 2.980

9.  Remission in psoriatic arthritis.

Authors:  Kurt de Vlam; Rik J U Lories
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

10.  Phenotypic and clinical differences between Caucasian and South Asian patients with psoriatic arthritis living in North East London.

Authors:  Euthalia Roussou; Sunil Chopra; Danny Lunda Ngandu
Journal:  Clin Rheumatol       Date:  2012-12-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.